BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11459259)

  • 1. Alendronate influences bending force of femoral diaphysis after orchidectomy in rats.
    Huuskonen J; Arnala I; Olkkonen H; Alhava E
    Ann Chir Gynaecol; 2001; 90(2):109-14. PubMed ID: 11459259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
    Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
    Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
    J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet.
    Kobayashi M; Hara K; Akiyama Y
    Bone; 2004 Nov; 35(5):1136-43. PubMed ID: 15542039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pamidronate increases trabecular bone mineral density in immobilization osteopenia in male rats.
    Huuskonen J; Arnala I; Olkkonen H; Alhava E
    Ann Chir Gynaecol; 2001; 90(1):37-42. PubMed ID: 11336368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies.
    Chavassieux PM; Arlot ME; Roux JP; Portero N; Daifotis A; Yates AJ; Hamdy NA; Malice MP; Freedholm D; Meunier PJ
    J Bone Miner Res; 2000 Apr; 15(4):754-62. PubMed ID: 10780867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis.
    Ding M; Danielsen CC; Hvid I
    Calcif Tissue Int; 2008 Jan; 82(1):77-86. PubMed ID: 18175032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
    Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM
    Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
    Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
    Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alendronate and strontium ranelate on cancellous and cortical bone mass in glucocorticoid-treated adult rats.
    Sun P; Cai DH; Li QN; Chen H; Deng WM; He L; Yang L
    Calcif Tissue Int; 2010 Jun; 86(6):495-501. PubMed ID: 20390406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate.
    Sugimoto M; Futaki N; Harada M; Kaku S
    Bone; 2013 Jan; 52(1):181-8. PubMed ID: 23041510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of short-term treatment with alendronate on ulnar bone adaptation to cyclic fatigue loading in rats.
    Barrett JG; Sample SJ; McCarthy J; Kalscheur VL; Muir P; Prokuski L
    J Orthop Res; 2007 Aug; 25(8):1070-7. PubMed ID: 17444501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable effects of alendronate and strontium ranelate on femur in ovariectomized rats.
    Chen B; Li Y; Yang X; Xie D
    Calcif Tissue Int; 2013 Nov; 93(5):481-6. PubMed ID: 23897224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat.
    Wezeman FH; Emanuele MA; Moskal SF; Steiner J; Lapaglia N
    J Bone Miner Res; 2000 Oct; 15(10):2033-41. PubMed ID: 11028458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alendronate and alfacalcidol on the femoral bone mass and bone strength in orchidectomized rats.
    Iwamoto J; Matsumoto H; Takeda T; Sato Y; Xu E; Yeh JK
    Chin J Physiol; 2008 Dec; 51(6):331-7. PubMed ID: 19280876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of concurrent administration of alendronate sodium and retinol on development of changes in histomorphometric parameters of bones induced by ovariectomy in rats.
    Pytlik M; Kaczmarczyk-Sedlak I; Sliwiński L; Janiec W; Rymkiewicz I
    Pol J Pharmacol; 2004; 56(5):571-9. PubMed ID: 15591645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onion decreases the ovariectomy-induced osteopenia in young adult rats.
    Huang TH; Mühlbauer RC; Tang CH; Chen HI; Chang GL; Huang YW; Lai YT; Lin HS; Yang WT; Yang RS
    Bone; 2008 Jun; 42(6):1154-63. PubMed ID: 18387868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
    McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
    Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alendronate prevents development of the skeletal changes induced by azathioprine in rats.
    Cegieła U; Kaczmarczyk-Sedlak I; Pytlik M; Folwarczna J; Nowińska B; Fronczek-Sokół J
    Acta Pol Pharm; 2013; 70(2):309-15. PubMed ID: 23614287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.